Vitafoods Europe 2026: Sabinsa’s ImmunoSpore postbiotic targets gut-immune health
23 Jun 2026 | Sabinsa
Sabinsa’s CEO, Shaheen Majeed, introduced the company’s latest ingredient ImmunoSpore. The heat-inactivated postbiotic derived from Lactospore supports intestinal barrier function, gut-immune signaling, and mucosal health. At the same time, Majeed said its postbiotic format offers greater formulation flexibility than probiotics across beverages and functional foods.
Subscribe to our newsletters
By continuing to browse our site you agree to our Privacy Statement


















